Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma

Documenti analoghi

• IT-03 ADOPTIVE TRANSFER OF IL13Rα2-SPECIFIC T CELLS FOR THE TREATMENT OF GLIOBLASTOMA: BUILDING ON CLINICAL ACHIEVEMENTS WITH SECOND-GENERATION CARs
  di: Brown, Christine, et al.
  Pubblicazione: (2014)
• IMMU-08. THERAPEUTIC POTENTIAL OF CHLOROTOXIN-REDIRECTED CAR-T CELLS AGAINST HETEROGENEOUS GLIOBLASTOMAS
  di: Wang, Dongrui, et al.
  Pubblicazione: (2017)
• Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
  di: Brown, Christine E., et al.
  Pubblicazione: (2018)
• Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
  di: Brown, Christine E, et al.
  Pubblicazione: (2013)
• Glioblastoma-targeted CD4(+) CAR T cells mediate superior antitumor activity
  di: Wang, Dongrui, et al.
  Pubblicazione: (2018)